Kardigan Eyes Public Listing to Advance Cardiology Pipeline Development Ukraines Drone Advancements Reshape Global Geopolitics and Defense Markets Samsung Ships Faster HBM4E Chip Samples to Customers Shares Gain BP Ousts Chair Albert Manifold Over Governance Lapses Shares Dip MarketSmith India Highlights Stock Recommendations for May 29 Hub Group Q3 2025 Earnings EPS Falls Short of Estimates Stock Declines TRTX Q1 2026 Earnings EPS Falls Short of Estimates Amid Narrow Miss YSG Q4 2025 Earnings Profitable Quarter Drives Stock Surge NKTR Q1 2026 Earnings WiderthanExpected Loss Amidst Pipeline Updates SDRL Q1 2026 Earnings NarrowerthanExpected Loss Boosts Surprise but Shares Slip Air Products and Chemicals APD Holds Near Key Levels After Slight Uptick Brighthouse Financial BHF Holds Steady Near Key Resistance Level Syntec Optics Holdings Warrant OPTXW Rallies 105 Key Resistance Test Ahead Flexible Solutions International FSI Pulls Back as Shares Approach Key Support Zone China Natural Resources Inc CHNR Slips 31 as Selling Pressure Tests Key Support Zone LPL Financial LPLA Rallies 298 Support Holds Resistance in Sight Jim Cramer Suggests Nvidia Could Benefit from Dells Strong Quarterly Performance WRD Q1 2026 Earnings WiderthanExpected Loss Highlights Operational Challenges Beyond to Acquire Buy Buy Baby Brand Rights Reuniting It With Bed Bath Beyond Three Signs from APEC Indicate US and China Remain Far Apart on Trade FFBC Q1 2026 Earnings EPS Surpasses Estimates by 8 Strengthening Investor Confidence Horizon Space Acquisition II Corp HSPT Holds Steady at 1001 Amid SPAC Market Calm VCTR Q1 2026 Earnings EPS Beats Estimates Amid Strong Operating Performance UCTT Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction MDCX Q1 2026 Earnings WiderthanExpected Loss No Revenue Stock Climbs 674 DBGI Q3 2023 Earnings Significant Loss Per Share Amid Stock Decline SNCY Q1 2026 Earnings EPS Miss Weighs on Results Revenue Details Pending CRESY Q1 2026 Earnings Robust EPS Driven by Operational Strength and Favorable Currency Adjustments Centessa Pharmaceuticals CNTA Q1 2026 Earnings EPS Miss Amid PreRevenue Phase Stock Slips Slightly